Broad Discovery Series: From genome editing to programmable medicine

August 15, 2023
Feng Zhang

Spurred by the development of CRISPR for genome editing, researchers have for 10 years been working to engineer modular, "programmable" treatments that accurately and consistently strike at the root causes of diseases. In this Broad Discovery Series event, molecular biologist and CRISPR pioneer Feng Zhang will invite past and present members of his lab to reflect on how the genome editing toolkit has expanded over the last decade, discuss other ways of developing programmable medicines, and talk about what gets them most excited about these technologies' potential.

This Broad Discovery Series talk will be held both in person and virtually. Those attending in person are invited to a reception in the Broad Discovery Center following the talk to celebrate the launch of both the Center and the new series.

Copyright Broad Institute, 2023. All rights reserved.